Revolution Medicines (RVMD) Times Interest Earned (2019 - 2026)

Name: Revolution Medicines (RVMD) Times Interest Earned (2019 - 2026) | Business Quant
Creator: Business Quant

Revolution Medicines' quarterly Times Interest Earned came in at -$36.5 in Q1 2026, up 23.27% quarter-over-quarter from -$47.57 in Q4 2025.

Revolution Medicines has reported Times Interest Earned for 6 years, with the latest figure at -$36.5 in Q1 2026.

For the quarter ending Q1 2026, Times Interest Earned changed N/A year-over-year to -$36.5; the trailing twelve-month figure through Mar 2026 stood at -$38.89 (changed N/A YoY), and the FY2025 full-year result was -$6420.9, changed N/A from the prior year.
Times Interest Earned for Q1 2026 stood at -$36.5, up from -$47.57 in the prior quarter.
The five-year high for Times Interest Earned was -$27.59 in Q3 2025, with the low at -$50.15 in Q1 2024.
Average Times Interest Earned over 3 years is -$40.45, with a median of -$42.04 recorded in 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Times Interest Earned (Qtr)
1	Quantum Biopharma	961,148.99 Bn	961,148.98 Bn	-	-129.79
2	Alterity Therapeutics	744,933.29 Bn	744,933.26 Bn	-	-
3	Legend Biotech	2,540.00 Bn	2,539.71 Bn	242.10 Mn	3.58
4	Nanobiotix	2,199.85 Bn	2,199.78 Bn	-	-
5	Akari Therapeutics	1,635.88 Bn	1,635.88 Bn	-	-258.33
6	Vertex Pharmaceuticals	111.32 Bn	104.07 Bn	2.59 Bn	-
7	Evaxion A	62.56 Bn	62.54 Bn	-	11.50
8	Regeneron Pharmaceuticals	62.55 Bn	53.79 Bn	3.31 Bn	49.84
9	Alnylam Pharmaceuticals	39.57 Bn	36.56 Bn	959.66 Mn	3.88
10	Revolution Medicines	32.39 Bn	32.39 Bn	-	-36.50

Download Data 🔒